Girls Mature Faster Than Boys.
New acumen research suggests one ground girls mature faster than boys during their teen years. As people age, their brains reorganize and mark down connections. In this study, scientists examined brain scans from 121 thriving people, aged 4 to 40. It's during this period that the major changes in capacity connectivity occur. The researchers discovered that although the overall number of connections is reduced, the intelligence preserves long-distance connections important for integrating information.
The findings might explain why brain act the part of doesn't decline - but instead improves - during this period of connection pruning, according to the check in team. The researchers also found that these changes in brain connections begin at an earlier age in girls than in boys. "Long-distance connections are grim to establish and maintain but are crucial for fast and efficient processing," said sanctum co-leader Marcus Kaiser, of Newcastle University, in England.
Showing posts with label information. Show all posts
Showing posts with label information. Show all posts
Tuesday 4 February 2020
Friday 13 January 2017
Promising Method For Early Diagnosis Of Cancer
Promising Method For Early Diagnosis Of Cancer.
A collaboration of US scientists and own companies are looking into a check-up that could find even one stray cancer apartment among the billions of cells that circulate in the human bloodstream. The hope is that one day such a test, given soon after a remedying is started, could indicate whether the therapy is working or not. It might even indicate beforehand which care would be most effective. The test relies on circulating tumor cells (CTCs) - cancer cells that have disinterested from the main tumor and are traveling to other parts of the body.
In 2007, researchers at Massachusetts General Hospital, developed a "microfluidic chip," called CellSearch, which could reckon the number of diverge cancer cells, but that test didn't allow scientists to trap whole cells and analyze them. But on Monday, Mass General announced an settlement with Veridex LLC, put of Johnson & Johnson, to study a newer version of the test.
According to the Associated Press, the updated trial requires only a couple of teaspoons of blood. The microchip is dotted with tens of thousands of little posts covered with antibodies designed to stick to tumor cells. As blood passes over the chip, tumor cells break from the pack and adhere to the posts.
A collaboration of US scientists and own companies are looking into a check-up that could find even one stray cancer apartment among the billions of cells that circulate in the human bloodstream. The hope is that one day such a test, given soon after a remedying is started, could indicate whether the therapy is working or not. It might even indicate beforehand which care would be most effective. The test relies on circulating tumor cells (CTCs) - cancer cells that have disinterested from the main tumor and are traveling to other parts of the body.
In 2007, researchers at Massachusetts General Hospital, developed a "microfluidic chip," called CellSearch, which could reckon the number of diverge cancer cells, but that test didn't allow scientists to trap whole cells and analyze them. But on Monday, Mass General announced an settlement with Veridex LLC, put of Johnson & Johnson, to study a newer version of the test.
According to the Associated Press, the updated trial requires only a couple of teaspoons of blood. The microchip is dotted with tens of thousands of little posts covered with antibodies designed to stick to tumor cells. As blood passes over the chip, tumor cells break from the pack and adhere to the posts.
Subscribe to:
Posts (Atom)